Anthera Pharmaceuticals Inc ANTH:Over The Counter Market

Last Price$0.0001Over The Counter Market Last Trade as of 9:38AM ET 12/01/21
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change-0.0001(50.00%)
Bid (Size)$0.0008 (10,000)
Ask (Size)$0.0214 (10,000)
Day Low / High$0.0001 - 0.0001
Volume156.0 K
 

View Biotechnology IndustryPeer Comparison as of 12/01/2021

 

Anthera Pharmaceuticals Inc ( OTC )

Price: $0.0001
Change: -0.0001 (50.00%)
Volume: 156.0 K
9:38AM ET 12/01/2021
 
 

Tengion Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 2.4 K
11:52AM ET 11/29/2021
 
 

Sophiris Bio Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 3.7 K
11:38AM ET 11/30/2021
 
 

ARYx Therapeutics Inc ( OTC )

Price: $0.0023
Change: 0.00 (0.00%)
Volume: 7.00
11:07AM ET 9/24/2021
 
 

BG Medicine Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 87.00
12:14PM ET 9/27/2021
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

Signify Health: The Best Contender In Innovative Healthcare
1:12PM ET 5/20/2021 Seeking Alpha

Company Profile

Business DescriptionAnthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA. View company web site for more details
Address25801 Industrial Boulevard
Hayward, California 94545
Phone+1.510.856.5600
Number of Employees21
SecretaryBradley A. Bugdanowitz

Company Highlights

Price Open$0.0001
Previous Close$0.0002
52 Week Range$0.0001 - 0.19
Market Capitalization$2.6 K
Shares Outstanding26.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.51
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-1,922.42%

Analyst Ratings as of 05/31/2018

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset